Senlin Zhang, Qi Ji, Qingwei Wang, Shaoyan Hu. "Prophylactic rituximab administered on day -1 during conditioning significantly reduces early EBV reactivation in pediatric allogeneic HSCT: Real-world evidence from a propensity-matched cohort of 834 patients." Blood (2025). https://doi.org/10.1182/blood-2025-5988